This study is assessing the safety and immune response of 3 experimental mRNA HIV vaccines in healthy, HIV negative adults between the ages of 18 to 55. This study is currently enrolling participants.
This trial is closed, but you can join our volunteer registry to be considered for participation in future clinical trials.